SUSPECTED ADVERSE DRUG REACTIONSTO FAVIPIRAVIR: INSIGHTS FROM EUDRAVIGILANCEREPORTS Article Swipe
Paul Andrei Negru
,
Delia Mirela Ţiţ
,
Simona Bungău
·
YOU?
·
· 2025
· Open Access
·
· DOI: https://doi.org/10.31688/abmu.2025.60.1.07
YOU?
·
· 2025
· Open Access
·
· DOI: https://doi.org/10.31688/abmu.2025.60.1.07
Related Topics
Concepts
Favipiravir
Drug reaction
Drug
Adverse drug reaction
Medicine
Adverse effect
Intensive care medicine
Pharmacology
Internal medicine
Coronavirus disease 2019 (COVID-19)
Disease
Infectious disease (medical specialty)
Metadata
- Type
- article
- Language
- en
- Landing Page
- https://doi.org/10.31688/abmu.2025.60.1.07
- OA Status
- gold
- Related Works
- 10
- OpenAlex ID
- https://openalex.org/W4409213439
All OpenAlex metadata
Raw OpenAlex JSON
- OpenAlex ID
-
https://openalex.org/W4409213439Canonical identifier for this work in OpenAlex
- DOI
-
https://doi.org/10.31688/abmu.2025.60.1.07Digital Object Identifier
- Title
-
SUSPECTED ADVERSE DRUG REACTIONSTO FAVIPIRAVIR: INSIGHTS FROM EUDRAVIGILANCEREPORTSWork title
- Type
-
articleOpenAlex work type
- Language
-
enPrimary language
- Publication year
-
2025Year of publication
- Publication date
-
2025-03-21Full publication date if available
- Authors
-
Paul Andrei Negru, Delia Mirela Ţiţ, Simona BungăuList of authors in order
- Landing page
-
https://doi.org/10.31688/abmu.2025.60.1.07Publisher landing page
- Open access
-
YesWhether a free full text is available
- OA status
-
goldOpen access status per OpenAlex
- OA URL
-
https://doi.org/10.31688/abmu.2025.60.1.07Direct OA link when available
- Concepts
-
Favipiravir, Drug reaction, Drug, Adverse drug reaction, Medicine, Adverse effect, Intensive care medicine, Pharmacology, Internal medicine, Coronavirus disease 2019 (COVID-19), Disease, Infectious disease (medical specialty)Top concepts (fields/topics) attached by OpenAlex
- Cited by
-
0Total citation count in OpenAlex
- Related works (count)
-
10Other works algorithmically related by OpenAlex
Full payload
| id | https://openalex.org/W4409213439 |
|---|---|
| doi | https://doi.org/10.31688/abmu.2025.60.1.07 |
| ids.doi | https://doi.org/10.31688/abmu.2025.60.1.07 |
| ids.openalex | https://openalex.org/W4409213439 |
| fwci | 0.0 |
| type | article |
| title | SUSPECTED ADVERSE DRUG REACTIONSTO FAVIPIRAVIR: INSIGHTS FROM EUDRAVIGILANCEREPORTS |
| biblio.issue | 1 |
| biblio.volume | 60 |
| biblio.last_page | 76 |
| biblio.first_page | 69 |
| topics[0].id | https://openalex.org/T11943 |
| topics[0].field.id | https://openalex.org/fields/30 |
| topics[0].field.display_name | Pharmacology, Toxicology and Pharmaceutics |
| topics[0].score | 0.9962999820709229 |
| topics[0].domain.id | https://openalex.org/domains/1 |
| topics[0].domain.display_name | Life Sciences |
| topics[0].subfield.id | https://openalex.org/subfields/3005 |
| topics[0].subfield.display_name | Toxicology |
| topics[0].display_name | Pharmacovigilance and Adverse Drug Reactions |
| topics[1].id | https://openalex.org/T11465 |
| topics[1].field.id | https://openalex.org/fields/30 |
| topics[1].field.display_name | Pharmacology, Toxicology and Pharmaceutics |
| topics[1].score | 0.9839000105857849 |
| topics[1].domain.id | https://openalex.org/domains/1 |
| topics[1].domain.display_name | Life Sciences |
| topics[1].subfield.id | https://openalex.org/subfields/3004 |
| topics[1].subfield.display_name | Pharmacology |
| topics[1].display_name | Drug-Induced Hepatotoxicity and Protection |
| topics[2].id | https://openalex.org/T10151 |
| topics[2].field.id | https://openalex.org/fields/27 |
| topics[2].field.display_name | Medicine |
| topics[2].score | 0.9836000204086304 |
| topics[2].domain.id | https://openalex.org/domains/4 |
| topics[2].domain.display_name | Health Sciences |
| topics[2].subfield.id | https://openalex.org/subfields/2721 |
| topics[2].subfield.display_name | Hepatology |
| topics[2].display_name | Hepatitis C virus research |
| is_xpac | False |
| apc_list.value | 110 |
| apc_list.currency | EUR |
| apc_list.value_usd | 118 |
| apc_paid.value | 110 |
| apc_paid.currency | EUR |
| apc_paid.value_usd | 118 |
| concepts[0].id | https://openalex.org/C2779772310 |
| concepts[0].level | 5 |
| concepts[0].score | 0.8081982135772705 |
| concepts[0].wikidata | https://www.wikidata.org/wiki/Q16934561 |
| concepts[0].display_name | Favipiravir |
| concepts[1].id | https://openalex.org/C2993432071 |
| concepts[1].level | 3 |
| concepts[1].score | 0.5884131789207458 |
| concepts[1].wikidata | https://www.wikidata.org/wiki/Q45959 |
| concepts[1].display_name | Drug reaction |
| concepts[2].id | https://openalex.org/C2780035454 |
| concepts[2].level | 2 |
| concepts[2].score | 0.5460475087165833 |
| concepts[2].wikidata | https://www.wikidata.org/wiki/Q8386 |
| concepts[2].display_name | Drug |
| concepts[3].id | https://openalex.org/C2780542314 |
| concepts[3].level | 3 |
| concepts[3].score | 0.5383153557777405 |
| concepts[3].wikidata | https://www.wikidata.org/wiki/Q45959 |
| concepts[3].display_name | Adverse drug reaction |
| concepts[4].id | https://openalex.org/C71924100 |
| concepts[4].level | 0 |
| concepts[4].score | 0.43050435185432434 |
| concepts[4].wikidata | https://www.wikidata.org/wiki/Q11190 |
| concepts[4].display_name | Medicine |
| concepts[5].id | https://openalex.org/C197934379 |
| concepts[5].level | 2 |
| concepts[5].score | 0.4154420793056488 |
| concepts[5].wikidata | https://www.wikidata.org/wiki/Q2047938 |
| concepts[5].display_name | Adverse effect |
| concepts[6].id | https://openalex.org/C177713679 |
| concepts[6].level | 1 |
| concepts[6].score | 0.38574111461639404 |
| concepts[6].wikidata | https://www.wikidata.org/wiki/Q679690 |
| concepts[6].display_name | Intensive care medicine |
| concepts[7].id | https://openalex.org/C98274493 |
| concepts[7].level | 1 |
| concepts[7].score | 0.29866135120391846 |
| concepts[7].wikidata | https://www.wikidata.org/wiki/Q128406 |
| concepts[7].display_name | Pharmacology |
| concepts[8].id | https://openalex.org/C126322002 |
| concepts[8].level | 1 |
| concepts[8].score | 0.19710499048233032 |
| concepts[8].wikidata | https://www.wikidata.org/wiki/Q11180 |
| concepts[8].display_name | Internal medicine |
| concepts[9].id | https://openalex.org/C3008058167 |
| concepts[9].level | 4 |
| concepts[9].score | 0.19149181246757507 |
| concepts[9].wikidata | https://www.wikidata.org/wiki/Q84263196 |
| concepts[9].display_name | Coronavirus disease 2019 (COVID-19) |
| concepts[10].id | https://openalex.org/C2779134260 |
| concepts[10].level | 2 |
| concepts[10].score | 0.05325973033905029 |
| concepts[10].wikidata | https://www.wikidata.org/wiki/Q12136 |
| concepts[10].display_name | Disease |
| concepts[11].id | https://openalex.org/C524204448 |
| concepts[11].level | 3 |
| concepts[11].score | 0.0 |
| concepts[11].wikidata | https://www.wikidata.org/wiki/Q788926 |
| concepts[11].display_name | Infectious disease (medical specialty) |
| keywords[0].id | https://openalex.org/keywords/favipiravir |
| keywords[0].score | 0.8081982135772705 |
| keywords[0].display_name | Favipiravir |
| keywords[1].id | https://openalex.org/keywords/drug-reaction |
| keywords[1].score | 0.5884131789207458 |
| keywords[1].display_name | Drug reaction |
| keywords[2].id | https://openalex.org/keywords/drug |
| keywords[2].score | 0.5460475087165833 |
| keywords[2].display_name | Drug |
| keywords[3].id | https://openalex.org/keywords/adverse-drug-reaction |
| keywords[3].score | 0.5383153557777405 |
| keywords[3].display_name | Adverse drug reaction |
| keywords[4].id | https://openalex.org/keywords/medicine |
| keywords[4].score | 0.43050435185432434 |
| keywords[4].display_name | Medicine |
| keywords[5].id | https://openalex.org/keywords/adverse-effect |
| keywords[5].score | 0.4154420793056488 |
| keywords[5].display_name | Adverse effect |
| keywords[6].id | https://openalex.org/keywords/intensive-care-medicine |
| keywords[6].score | 0.38574111461639404 |
| keywords[6].display_name | Intensive care medicine |
| keywords[7].id | https://openalex.org/keywords/pharmacology |
| keywords[7].score | 0.29866135120391846 |
| keywords[7].display_name | Pharmacology |
| keywords[8].id | https://openalex.org/keywords/internal-medicine |
| keywords[8].score | 0.19710499048233032 |
| keywords[8].display_name | Internal medicine |
| keywords[9].id | https://openalex.org/keywords/coronavirus-disease-2019 |
| keywords[9].score | 0.19149181246757507 |
| keywords[9].display_name | Coronavirus disease 2019 (COVID-19) |
| keywords[10].id | https://openalex.org/keywords/disease |
| keywords[10].score | 0.05325973033905029 |
| keywords[10].display_name | Disease |
| language | en |
| locations[0].id | doi:10.31688/abmu.2025.60.1.07 |
| locations[0].is_oa | True |
| locations[0].source.id | https://openalex.org/S4210173113 |
| locations[0].source.issn | 1584-9244, 2558-815X |
| locations[0].source.type | journal |
| locations[0].source.is_oa | True |
| locations[0].source.issn_l | 1584-9244 |
| locations[0].source.is_core | False |
| locations[0].source.is_in_doaj | True |
| locations[0].source.display_name | Archives of the Balkan Medical Union |
| locations[0].source.host_organization | https://openalex.org/P4310314695 |
| locations[0].source.host_organization_name | Balkan Medical Union |
| locations[0].source.host_organization_lineage | https://openalex.org/P4310314695 |
| locations[0].license | cc-by-nc |
| locations[0].pdf_url | |
| locations[0].version | publishedVersion |
| locations[0].raw_type | journal-article |
| locations[0].license_id | https://openalex.org/licenses/cc-by-nc |
| locations[0].is_accepted | True |
| locations[0].is_published | True |
| locations[0].raw_source_name | Archives of the Balkan Medical Union |
| locations[0].landing_page_url | https://doi.org/10.31688/abmu.2025.60.1.07 |
| indexed_in | crossref, doaj |
| authorships[0].author.id | https://openalex.org/A5023020619 |
| authorships[0].author.orcid | https://orcid.org/0000-0001-9898-0753 |
| authorships[0].author.display_name | Paul Andrei Negru |
| authorships[0].author_position | first |
| authorships[0].raw_author_name | Paul A. NEGRU |
| authorships[0].is_corresponding | False |
| authorships[1].author.id | https://openalex.org/A5038952512 |
| authorships[1].author.orcid | https://orcid.org/0000-0002-0296-6592 |
| authorships[1].author.display_name | Delia Mirela Ţiţ |
| authorships[1].author_position | middle |
| authorships[1].raw_author_name | Delia M. TIT |
| authorships[1].is_corresponding | False |
| authorships[2].author.id | https://openalex.org/A5069616412 |
| authorships[2].author.orcid | |
| authorships[2].author.display_name | Simona Bungău |
| authorships[2].author_position | last |
| authorships[2].raw_author_name | Simona G. BUNGAU |
| authorships[2].is_corresponding | False |
| has_content.pdf | False |
| has_content.grobid_xml | False |
| is_paratext | False |
| open_access.is_oa | True |
| open_access.oa_url | https://doi.org/10.31688/abmu.2025.60.1.07 |
| open_access.oa_status | gold |
| open_access.any_repository_has_fulltext | False |
| created_date | 2025-04-07T00:00:00 |
| display_name | SUSPECTED ADVERSE DRUG REACTIONSTO FAVIPIRAVIR: INSIGHTS FROM EUDRAVIGILANCEREPORTS |
| has_fulltext | False |
| is_retracted | False |
| updated_date | 2025-11-06T03:46:38.306776 |
| primary_topic.id | https://openalex.org/T11943 |
| primary_topic.field.id | https://openalex.org/fields/30 |
| primary_topic.field.display_name | Pharmacology, Toxicology and Pharmaceutics |
| primary_topic.score | 0.9962999820709229 |
| primary_topic.domain.id | https://openalex.org/domains/1 |
| primary_topic.domain.display_name | Life Sciences |
| primary_topic.subfield.id | https://openalex.org/subfields/3005 |
| primary_topic.subfield.display_name | Toxicology |
| primary_topic.display_name | Pharmacovigilance and Adverse Drug Reactions |
| related_works | https://openalex.org/W111277538, https://openalex.org/W2544208578, https://openalex.org/W2044946730, https://openalex.org/W2377651601, https://openalex.org/W2378947884, https://openalex.org/W2376885761, https://openalex.org/W2995438986, https://openalex.org/W2398395680, https://openalex.org/W2365386954, https://openalex.org/W2377282230 |
| cited_by_count | 0 |
| locations_count | 1 |
| best_oa_location.id | doi:10.31688/abmu.2025.60.1.07 |
| best_oa_location.is_oa | True |
| best_oa_location.source.id | https://openalex.org/S4210173113 |
| best_oa_location.source.issn | 1584-9244, 2558-815X |
| best_oa_location.source.type | journal |
| best_oa_location.source.is_oa | True |
| best_oa_location.source.issn_l | 1584-9244 |
| best_oa_location.source.is_core | False |
| best_oa_location.source.is_in_doaj | True |
| best_oa_location.source.display_name | Archives of the Balkan Medical Union |
| best_oa_location.source.host_organization | https://openalex.org/P4310314695 |
| best_oa_location.source.host_organization_name | Balkan Medical Union |
| best_oa_location.source.host_organization_lineage | https://openalex.org/P4310314695 |
| best_oa_location.license | cc-by-nc |
| best_oa_location.pdf_url | |
| best_oa_location.version | publishedVersion |
| best_oa_location.raw_type | journal-article |
| best_oa_location.license_id | https://openalex.org/licenses/cc-by-nc |
| best_oa_location.is_accepted | True |
| best_oa_location.is_published | True |
| best_oa_location.raw_source_name | Archives of the Balkan Medical Union |
| best_oa_location.landing_page_url | https://doi.org/10.31688/abmu.2025.60.1.07 |
| primary_location.id | doi:10.31688/abmu.2025.60.1.07 |
| primary_location.is_oa | True |
| primary_location.source.id | https://openalex.org/S4210173113 |
| primary_location.source.issn | 1584-9244, 2558-815X |
| primary_location.source.type | journal |
| primary_location.source.is_oa | True |
| primary_location.source.issn_l | 1584-9244 |
| primary_location.source.is_core | False |
| primary_location.source.is_in_doaj | True |
| primary_location.source.display_name | Archives of the Balkan Medical Union |
| primary_location.source.host_organization | https://openalex.org/P4310314695 |
| primary_location.source.host_organization_name | Balkan Medical Union |
| primary_location.source.host_organization_lineage | https://openalex.org/P4310314695 |
| primary_location.license | cc-by-nc |
| primary_location.pdf_url | |
| primary_location.version | publishedVersion |
| primary_location.raw_type | journal-article |
| primary_location.license_id | https://openalex.org/licenses/cc-by-nc |
| primary_location.is_accepted | True |
| primary_location.is_published | True |
| primary_location.raw_source_name | Archives of the Balkan Medical Union |
| primary_location.landing_page_url | https://doi.org/10.31688/abmu.2025.60.1.07 |
| publication_date | 2025-03-21 |
| publication_year | 2025 |
| referenced_works_count | 0 |
| abstract_inverted_index | |
| cited_by_percentile_year | |
| countries_distinct_count | 0 |
| institutions_distinct_count | 3 |
| citation_normalized_percentile.value | 0.11787949 |
| citation_normalized_percentile.is_in_top_1_percent | False |
| citation_normalized_percentile.is_in_top_10_percent | False |